Pitogo, Mark Jasper V.
HRN: 25-69-30 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/01/2024
09/08/2024
TIV
300mg
Q6
Mandibular Fracture Sec To MVA
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes